22 Jul 2026Open access
Serum fibroblast growth factor-19 as a diagnostic biomarker of hepatocellular carcinoma and indicator of portal vein thrombosis: a cross-sectional studyPublisher siteEgyptian Liver Journal, Fibroblast Growth Factor Research
Active, last published 2026
In liver disease diagnosis and treatment
Mostafa
Elazab
Scholar“Research focused on Liver Disease Diagnosis and Treatment and adjacent fields.”
Claim Your Profile2
H-index
17
Citations
Mostafa has not officially claimed their profile. If you are Mostafa, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ostafa Elazab is a researcher working on Liver Disease Diagnosis and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mostafa's work has been cited 17 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Liver Disease Diagnosis and Treatment×2
04 · Where I am
Affiliations
Affiliation on published researchKafrelsheikh University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works6 Jul 2023Open access4cites
Schistosomal (bilharzial) polyps: Travel through the colon and beyondPublisher siteWorld Journal of Gastroenterology, Parasites and Host Interactions
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mostafa?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you